1. Home
  2. Knowledge Base
  3. References
  4. Alteration of BDNF and noradrenergic markers in locus coeruleus in a mouse model of cancer-induced bone pain

Alteration of BDNF and noradrenergic markers in locus coeruleus in a mouse model of cancer-induced bone pain

Yuan M, Zhang L, Zhu H, Xie M (2025) Alteration of BDNF and noradrenergic markers in locus coeruleus in a mouse model of cancer-induced bone pain. PLoS One 20(8):e0330207. doi: 10.1371/journal.pone.0330207 PMID: 40811566

Objective: To examine the expression and localization of BDNF and NE neuron-specific proteins in the locus coeruleus (LC) of mice with cancer-induced bone pain (CIBP).

Summary: CIBP mice exhibited enhanced neuronal activity in the LC, upregulation of noradrenergic markers, and BDNF/TrkB-mediated modulation of noradrenergic neurons. Concurrently, inhibitory signalling was attenuated in the spinal dorsal horn (SDH).

Usage: Selective ablation of noradrenergic neurons via intracerebroventricular anti-DBH-SAP (IT-03) administration reduces mechanical and cold allodynia, suggesting that LC-spinal cord pathway activity is critical for pain modulation.

Related Products: Anti-DBH-SAP (Cat. #IT-03)

See Also:

Shopping Cart
Scroll to Top